These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16518710)

  • 21. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.
    Gómez-Garcés JL; Alos JI; Tamayo J
    Int J Antimicrob Agents; 2007 Jun; 29(6):688-92. PubMed ID: 17475450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro selection of fluoroquinolone resistance in Brucella melitensis.
    Ravanel N; Gestin B; Maurin M
    Int J Antimicrob Agents; 2009 Jul; 34(1):76-81. PubMed ID: 19261448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study.
    Farrell DJ; File TM; Jenkins SG
    J Clin Microbiol; 2007 Feb; 45(2):290-3. PubMed ID: 17093012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
    Morrissey I; Colclough A; Northwood J
    Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of Bacillus anthracis to eleven antimicrobial agents including novel fluoroquinolones and a ketolide.
    Frean J; Klugman KP; Arntzen L; Bukofzer S
    J Antimicrob Chemother; 2003 Aug; 52(2):297-9. PubMed ID: 12865385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.
    Sahm DF; Brown NP; Draghi DC; Evangelista AT; Yee YC; Thornsberry C
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):8-15. PubMed ID: 18931466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae.
    Allen GP; Hankins CD
    J Antimicrob Chemother; 2009 Aug; 64(2):359-63. PubMed ID: 19460783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
    Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
    Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrolide antibiotics and asthma treatment.
    Johnston SL
    J Allergy Clin Immunol; 2006 Jun; 117(6):1233-6. PubMed ID: 16750980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes.
    Roberts MC
    FEMS Microbiol Lett; 2008 May; 282(2):147-59. PubMed ID: 18399991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
    Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ
    Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative structure-activity relationships among macrolide antibacterial agents: in vitro and in vivo potency against Pasteurella multocida.
    McFarland JW; Berger CM; Froshauer SA; Hayashi SF; Hecker SJ; Jaynes BH; Jefson MR; Kamicker BJ; Lipinski CA; Lundy KM; Reese CP; Vu CB
    J Med Chem; 1997 Apr; 40(9):1340-6. PubMed ID: 9135031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
    Hoban DJ; Zhanel GG
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-9 Alkenylidine bridged macrolides: WO2008061189. Enanta Pharmaceuticals, Inc.
    Poce G; Cesare Porretta G; Biava M
    Expert Opin Ther Pat; 2009 Jun; 19(6):901-6. PubMed ID: 19473109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
    Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
    J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panels.
    Ross JE; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):219-21. PubMed ID: 15766610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.
    Bogaerts P; Berhin C; Nizet H; Glupczynski Y
    Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics.
    Drusano GL
    Pharmacotherapy; 2005 Dec; 25(12 Pt 2):150S-158S. PubMed ID: 16305286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.